Cargando…
T follicular helper cells: linking cancer immunotherapy and immune-related adverse events
Cancer immunotherapy utilizing immune checkpoint inhibitors (ICIs) has revolutionized the treatment of numerous cancer types. As the underlying mechanism of these treatments lies in the interference with inhibitory signals that usually impair potent antitumor immunity, for example, cytotoxic T-lymph...
Autores principales: | Baumjohann, Dirk, Brossart, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194326/ https://www.ncbi.nlm.nih.gov/pubmed/34112740 http://dx.doi.org/10.1136/jitc-2021-002588 |
Ejemplares similares
-
Correction: T follicular helper cells: linking cancer immunotherapy and immune-related adverse events
Publicado: (2021) -
Posttranscriptional Gene Regulation of T Follicular Helper Cells by RNA-Binding Proteins and microRNAs
por: Baumjohann, Dirk, et al.
Publicado: (2018) -
Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021) -
T-helper 1 versus T-helper 2 lymphocyte immunodysregulation is the central factor in genesis of Burkitt lymphoma: hypothesis
por: Lubega, Joseph
Publicado: (2007) -
Are the adverse effects of glitazones linked to induced testosterone deficiency?
por: Carruthers, M, et al.
Publicado: (2008)